Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Page 1
COVID-19 in Lung Transplant Recipients: 2 Cases With Acute Respiratory Distress Syndrome Successfully Treated With High-Dose Corticosteroids.
Brugiere O, Neuville M, Le Balch P, Le Tulzo Y, Brun AL, Hamid A, Beaumont L, Roux A, Jouneau S, Parquin F. Brugiere O, et al. Among authors: jouneau s. Exp Clin Transplant. 2021 Jul;19(7):744-748. doi: 10.6002/ect.2021.0007. Epub 2021 Jun 3. Exp Clin Transplant. 2021. PMID: 34085913 Free article.
Both cases of acute respiratory distress syndrome occurred in patients with long-term azithromycin treatment prescribed to prevent chronic allograft dysfunction. ...Our findings support the benefit of early high-dose corticosteroids in COVID-19-related acute respiratory di …
Both cases of acute respiratory distress syndrome occurred in patients with long-term azithromycin treatment prescribed to prevent ch …
French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).
Terrier B, Darbon R, Durel CA, Hachulla E, Karras A, Maillard H, Papo T, Puechal X, Pugnet G, Quemeneur T, Samson M, Taille C, Guillevin L; Collaborators. Terrier B, et al. Orphanet J Rare Dis. 2020 Dec 29;15(Suppl 2):351. doi: 10.1186/s13023-020-01621-3. Orphanet J Rare Dis. 2020. PMID: 33372616 Free PMC article. Review.
The management goals are: to obtain remission and, in the long term, healing; to reduce the risk of relapses; to limit and reduce the sequelae linked to the disease; to limit the side effects and the sequelae linked to the treatments; to improve or at least maintain the be …
The management goals are: to obtain remission and, in the long term, healing; to reduce the risk of relapses; to limit and reduce the …
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020.
Bénézit F, Le Bot A, Jouneau S, Lemaître F, Pronier C, Lentz PA, Patrat-Delon S, Revest M, Thibault V, Tattevin P. Bénézit F, et al. Among authors: jouneau s. Emerg Infect Dis. 2020 Oct;26(10):2513-2515. doi: 10.3201/eid2610.201816. Epub 2020 Jul 1. Emerg Infect Dis. 2020. PMID: 32609083 Free PMC article.
We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19 despite adequate plasma concentrations....
We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted CO …
A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT.
Jouneau S, Gamez AS, Traclet J, Nunes H, Marchand-Adam S, Kessler R, Israël-Biet D, Borie R, Strombom I, Scalori A, Crestani B, Valeyre D, Cottin V. Jouneau S, et al. Respiration. 2019;98(1):19-28. doi: 10.1159/000496735. Epub 2019 Apr 9. Respiration. 2019. PMID: 30965332 Free article.
BACKGROUND: The European observational, prospective PASSPORT study evaluated the long-term safety of pirfenidone under real-world conditions in idiopathic pulmonary fibrosis (IPF), over up to 2 years following its initiation. ...
BACKGROUND: The European observational, prospective PASSPORT study evaluated the long-term safety of pirfenidone under real-world con …
Women and COPD: do we need more evidence?
Gut-Gobert C, Cavaillès A, Dixmier A, Guillot S, Jouneau S, Leroyer C, Marchand-Adam S, Marquette D, Meurice JC, Desvigne N, Morel H, Person-Tacnet C, Raherison C. Gut-Gobert C, et al. Among authors: jouneau s. Eur Respir Rev. 2019 Feb 27;28(151):180055. doi: 10.1183/16000617.0055-2018. Print 2019 Mar 31. Eur Respir Rev. 2019. PMID: 30814138 Free PMC article. Review.
While these differences require appropriate therapeutic responses (smoking cessation, pulmonary rehabilitation, long-term oxygen therapy), barriers to the treatment of women with COPD include greater under-diagnosis than in men, fewer spirometry tests and medical consultat …
While these differences require appropriate therapeutic responses (smoking cessation, pulmonary rehabilitation, long-term oxygen ther …
Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy.
Girard A, Jouneau S, Chabanne C, Khouatra C, Lannes M, Traclet J, Turquier S, Delaval P, Cordier JF, Cottin V. Girard A, et al. Among authors: jouneau s. Respiration. 2015;90(3):220-8. doi: 10.1159/000431380. Epub 2015 Aug 5. Respiration. 2015. PMID: 26277885 Free article.
Appropriate prospective randomized studies are needed to evaluate the potential long-term clinical benefit of treatment....
Appropriate prospective randomized studies are needed to evaluate the potential long-term clinical benefit of treatment....
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puéchal X, Aumaître O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogué B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L; French Vasculitis Study Group. Comarmond C, et al. Among authors: jouneau s. Arthritis Rheum. 2013 Jan;65(1):270-81. doi: 10.1002/art.37721. Arthritis Rheum. 2013. PMID: 23044708 Free article.
This study was undertaken to describe the main characteristics of a larger patient cohort and their long-term outcomes. METHODS: A retrospective study of EGPA patients in the French Vasculitis Study Group cohort who satisfied the American College of Rheumatology criteria a …
This study was undertaken to describe the main characteristics of a larger patient cohort and their long-term outcomes. METHODS: A re …
Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP, Vittecoq O, Noel D, Mouthon L, Menard JF, Jouen F. Marie I, et al. Among authors: jouneau s. Autoimmun Rev. 2012 Aug;11(10):739-45. doi: 10.1016/j.autrev.2012.01.006. Epub 2012 Feb 3. Autoimmun Rev. 2012. PMID: 22326685 Review.
Taken together, although anti-Jo1 positive patients with ASS share some features with those with anti-PL7/PL12 antibody, they exhibit many differences regarding clinical phenotype and long-term outcome. Our study underscores that the presence of anti-Jo1 antibody results i …
Taken together, although anti-Jo1 positive patients with ASS share some features with those with anti-PL7/PL12 antibody, they exhibit many d …
Endoscopic management of idiopathic tracheal stenosis.
Perotin JM, Jeanfaivre T, Thibout Y, Jouneau S, Lena H, Dutau H, Ramon P, Lorut C, Noppen M, Vergnon JM, Vallerand H, Merol JC, Marquette CH, Lebargy F, Deslee G. Perotin JM, et al. Among authors: jouneau s. Ann Thorac Surg. 2011 Jul;92(1):297-301. doi: 10.1016/j.athoracsur.2011.03.129. Ann Thorac Surg. 2011. PMID: 21718860
BACKGROUND: Idiopathic tracheal stenosis (ITS) is a rare condition representing a difficult therapeutic challenge. Endoscopic management is a therapeutic option but long-term results are not established. The aim of this retrospective multicenter study was to analyze long- …
BACKGROUND: Idiopathic tracheal stenosis (ITS) is a rare condition representing a difficult therapeutic challenge. Endoscopic management is …
11 results